Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma

Clinical trial NCT00308607 · COMPLETED

Trial details

NCT number: NCT00308607
Sponsor: University of Turku
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Melanoma

Start date: 2005-08-01
Primary completion: 2008-12-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.